$NMR

Nagai Koji sold (to issuer) 220,643 shares of NMR

Nagai Koji sold (to issuer) 220,643 shares of NOMURA HOLDINGS INC (NMR) on 2026-04-24.

Original reporting
SEC EDGAR · Nagai Koji
Published Apr 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 9:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NMR
Neutral
medium confidence
Mentioned
$NMR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NMRNeutralLow
01

Why it matters

The newest fact is the disclosed sale of 220,643 shares to the issuer on 2026-04-24, reported on 2026-04-28, with no 10b5-1 plan and undisclosed price/value.

02

Market read

Traders may note the insider sale details, but the filing provides limited actionable information because transaction price/value is not disclosed and the event appears routine.

03

What to watch

Price and total value are not disclosed, and the sale is to the issuer, which can reflect structured programs or liquidity needs rather than a bearish view.

Relevance 4/10Novelty 4/10Timing: filed 2026-04-28 after-hours; transaction dated 2026-04-24

Background

The article is an SEC Form 4 insider transaction disclosure for Nomura Holdings Inc, reported by director Koji Nagai.

Company-level read

Ticker impact

$NMRNeutralMedium confidence
Context

Nomura Holdings director Nagai Koji sold 220,643 shares to the issuer via Form 4, with price undisclosed and no 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move based solely on this Form 4; any reaction would be short-lived and sentiment-driven.

Evidence & confidence

The filing is primary-source but lacks disclosed transaction price/value and states no pre-arranged 10b5-1 plan, which reduces interpretability. Insider sales are common and often not directionally informative without additional context.

Market effects

Minimal. Insider sale filings typically do not change sector fundamentals for financials.

Minimal. No Japan-specific macro or regulatory catalyst is disclosed.

Minimal. The event is company-specific and routine in nature.

Counterpoint

The absence of a 10b5-1 plan could be interpreted by some traders as less “mechanical,” potentially increasing short-term scrutiny of insider intent.

Key entities

  • NOMURA HOLDINGS INC

    Company whose director insider sale to the issuer is disclosed on Form 4.

  • Nagai Koji

    Director who sold 220,643 shares to the issuer; holdings after transaction were 512,942 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NMRHigh

NOMURA HOLDINGS INC (NMR): Financial results for H2 2026

NOMURA HOLDINGS INC (NMR) furnished an SEC Form 6-K — earnings release. Table of Contents Information furnished on this form: EXHIBIT Exhibit Number 1. Financial Summary – Six months ended September 30, 2026. The registrant hereby incorporates Exhibit 1 to this report on Form 6-K by reference (i) in the prospectus that is part of the Registration Sta

$NMRHigh

NOMURA HOLDINGS INC (NMR): Financial results for Q2 2026

NOMURA HOLDINGS INC (NMR) furnished an SEC Form 6-K — earnings release. Information furnished on this form: EXHIBIT Exhibit Number 1. Supplement for Financial Highlights – Three months ended June 30, 2026 The registrant hereby incorporates Exhibit 1 to this report on Form 6-K by reference (i) in the prospectus that is part of the Registration Stateme